Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 143

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part II, Item 5
Chunk 143
---
Table of Contents

Item 5. OTHER INFORMATION

Rule 10b5-1 Trading PlansThe following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted by our directors and executive officers during the quarter ended June 30, 2025. No trading arrangements were terminated by our directors and executive officers during the quarter ended June 30, 2025. Trading ArrangementName and PositionActionDateRule 10b5-1*Non-Rule10b5-1**Total Number ofShares to be SoldExpirationDateAbraham CeesayDirectorAdopt6/3/2025x2,3549/4/2025Shawn M. CrossChief Financial OfficerAdopt6/9/2025xTo Be Determined (1)5/29/2026Lauren RikerPrincipal Accounting OfficerAdopt6/13/2025xTo Be Determined (1) (2)2/3/2026 * Intended to satisfy the affirmative defense of Rule 10b5-1(c).** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).(1) The aggregate number of shares to be sold pursuant to the trading arrangements listed above are dependent on the amount of tax withholding required upon the vesting of restricted stock units, and, therefore, is indeterminable at this time.(2) Includes shares to be sold which are scheduled to be purchased through the Company’s employee stock purchase plan on December 31, 2025.